Drug Development

2 articles

Futuristic AI interface displaying molecular structures and clinical trial data, symbolizing accelerated drug discovery and oncology research.

AI accelerates oncology trials, FDA shapes AI-driven research

A novel AI-generated TNIK inhibitor recently completed a Phase 2a trial for idiopathic pulmonary fibrosis, demonstrating AI's shift from data analysis to active therapeutic compound design.

Arjun Mehta·May 15, 2026

A futuristic lab scene with scientists interacting with holographic data and advanced screens, symbolizing Certis Oncology's AI platform integrating predictive AI with biological validation for cancer research.

Certis Oncology Launches AI-Powered Oncology Intelligence Platform

Certis Oncology has launched its new AI-powered Intelligence Platform, designed to advance cancer research by integrating predictive and agentic artificial intelligence with biological validation. This system aims to accelerate drug development and improve therapeutic response predictions.

Arjun Mehta·March 30, 2026